SCHEMBL3727160

SCHEMBL3727160

Cc1ccccc1S(=O)(=O)N(c1ccccc1)[C@H]1CCN(C(=O)O)C(CCCN(Cc2ccccc2)Cc2ccccc2)C1.O=C(O)N1CCC(Nc2ccccc2)CC1

nearest known ligand 0.38

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 5/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ NSD2 O96028 2/20 0.33
▸ CCR5 P51681 2/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ CCR8 P51685 2/20 0.32
▸ HTR2A P28223 1/20 0.32
▸ HTR2C P28335 1/20 0.32
▸ PTPRB P23467 1/20 0.32
▸ PTPN11 Q06124 1/20 0.32
▸ AGTR2 P50052 2/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3724470 0.86 HTR2A (0.37) RORCCCR5KCNH2HTR2AHTR2C
SCHEMBL4783965 0.78 CHRM2 (0.44) —
SCHEMBL3663968 0.77 NSD2 (0.34) RORCALDH1A1NSD2
SCHEMBL3722537 0.76 OPRM1 (0.39) HTR2AHTR2CAGTR2
SCHEMBL3723935 0.75 MCL1 (0.39) ALDH1A1KCNH2HTR2AHTR2C
SCHEMBL3728078 0.74 HTR7 (0.37) ALDH1A1HTR2AHTR2CNPSR1
SCHEMBL4786234 0.73 DPP7 (0.39) RORCALDH1A1
SCHEMBL4731396 0.73 KCNH2 (0.40) RORCALDH1A1KCNH2
SCHEMBL3724780 0.73 TAS2R14 (0.44) HTR2AHTR2CNPSR1
SCHEMBL4738420 0.72 ALDH1A1 (0.39) ALDH1A1CCR5KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155676-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS Commissariat à l'Energie Atomique (FR) 2010-02-24 — — EP disclosed
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 — — WO disclosed
Send feedback